Food

EzCater Gobbles $35M From Iconiq Capital, Insight Venture Partners

3 monthes ago   |   By Xconomy

Boston online food-ordering company ezCater has hauled in another big venture capital round. Today the company announced a $35 million investment led by new backer Iconiq Capital; Insight Venture Partners, a previous ezCater investor, also chipped in. EzCater says it has raised $70 million in total venture capital, including a $28 million round announced in October 2015 . EzCater got started in 2007, before there was a glut of companies offering food delivery at the push of a smartphone button. But while most online food-ordering startups have targeted consumers, ezCater opted to serve...
Read more ...

 


Search by Tags

   Food      Boston      Boston blog main      Boston top stories      National blog main      Apps      David Meiselman      EzCater      Food delivery      Food ordering      Iconiq Capital      Insight Venture Partners      Mobile      On demand      Software      Startups      Stefania Mallett      Tech      VC  


Bio Roundup: Trumpcare Flails, Spinraza Sales, Batten OK & More

To judge the first 100 days of a new administration is, as many pundits have pointed out, an odd vestige of history, more convenient than significant. Which is why we'll start... Read more ...

Pulling the Plug on the First Gene Therapy Drug

2017 is supposed to be the year that FDA finally approves a gene therapy. But last week, the company behind the first approved gene therapy in Europe, uniQure.com , announced... Read more ...

A Multi-Classifier System for Automatic Mitosis Detection in Breast...

Sabeena Beevi K , Madhu S. Nair , Bindu G. R. Early Access Note: Early Access articles are new content made available in advance of the final electronic or print versions and... Read more ...

Gottlieb's FDA Nomination Gets Committee Nod, Advances to Senate

Scott Gottlieb's nomination to the top post of the FDA is on its way to the full U.S. Senate. The Senate Health, Education, Labor & Pensions Committee voted 14-9 on Thursday to... Read more ...

Will New Data Open “Bottlenecks” For Biogen's Pricey Spine Drug?

Four months after its drug nusinersen became the first ever approved to treat the rare genetic disease spinal muscular atrophy, Biogen released study results Tuesday that could... Read more ...

Gates Foundation Leads $45.5M Round for Gerngross' Biotech Arsanis

Arsanis, a Waltham, MA-based biotech co-founded by scientist and entrepreneur Tillman Gerngross to develop treatments for bacterial and viral infections, has raised a $45.5... Read more ...

The Medicines Co., Alnylam Take Plunge, Outline Big Test For Heart Drug

The Medicines Co. and Alnylam Pharmaceuticals have come to a deal with the FDA on the big Phase 3 test for their RNA-based cholesterol-lowering drug, inclisiran, a potentially... Read more ...

Joining G20, Troiano Is Latest Boston Tech Exec to Move Into VC

Mike Troiano doesn't sit still. In fact, it's hard to believe he has been chief marketing officer at enterprise IT firm Actifio for five years. But now he has taken a full-time... Read more ...

Veering Off Topic With Adelphic Co-founder Jennifer Lum

Next up in my ongoing series of offbeat chats with local tech execs and investors is Jennifer Lum. Lum is a leader in Boston's mobile advertising sector, having co-founded or... Read more ...

Seattle Week in Review: Amazon, Indy Bookstores, and Serendipity

Amazon, the behemoth of digital and physical commerce, started out as an independent bookseller, albeit an online one, based in a home in Bellevue, WA. Now that it's doing... Read more ...